Rice Hall James & Associates, LLC Insmed Inc Transaction History

Rice Hall James & Associates, LLC

  • $1.53 Billion
  • Q1 2025

A detailed history of Rice Hall James & Associates, LLC transactions in Insmed Inc stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 88,041 shares of INSM stock, worth $8.59 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
88,041
Previous 88,860 0.92%
Holding current value
$8.59 Million
Previous $6.13 Million 9.49%
% of portfolio
0.44%
Previous 0.37%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 01, 2025
SELL
$65.25 - $83.83 $53,439 - $68,656
-819 Reduced 0.92%
88,041 $6.72 Million
Q4 2024

Jan 31, 2025
SELL
$66.29 - $76.63 $307,055 - $354,950
-4,632 Reduced 4.95%
88,860 $6.13 Million
Q3 2024

Oct 28, 2024
SELL
$62.0 - $79.01 $206,584 - $263,261
-3,332 Reduced 3.44%
93,492 $6.82 Million
Q2 2024

Aug 07, 2024
SELL
$22.0 - $69.71 $1.82 Million - $5.75 Million
-82,508 Reduced 46.01%
96,824 $6.49 Million
Q1 2024

Apr 23, 2024
SELL
$25.72 - $29.94 $1.08 Million - $1.26 Million
-41,938 Reduced 18.95%
179,332 $4.87 Million
Q4 2023

Feb 08, 2024
SELL
$23.42 - $31.74 $74,826 - $101,409
-3,195 Reduced 1.42%
221,270 $6.86 Million
Q3 2023

Nov 02, 2023
SELL
$19.86 - $26.93 $95,864 - $129,991
-4,827 Reduced 2.11%
224,465 $5.67 Million
Q2 2023

Jul 24, 2023
SELL
$16.44 - $21.1 $28,934 - $37,136
-1,760 Reduced 0.76%
229,292 $4.84 Million
Q1 2023

May 11, 2023
SELL
$16.26 - $21.73 $268,891 - $359,349
-16,537 Reduced 6.68%
231,052 $3.94 Million
Q4 2022

Jan 27, 2023
SELL
$16.98 - $23.15 $22,770 - $31,044
-1,341 Reduced 0.54%
247,589 $0
Q3 2022

Nov 01, 2022
SELL
$20.88 - $28.21 $1.32 Million - $1.78 Million
-63,154 Reduced 20.24%
248,930 $5.36 Million
Q2 2022

Aug 08, 2022
BUY
$17.07 - $25.71 $613,410 - $923,888
35,935 Added 13.01%
312,084 $6.15 Million
Q1 2022

May 05, 2022
SELL
$20.42 - $28.13 $101,630 - $140,003
-4,977 Reduced 1.77%
276,149 $6.49 Million
Q4 2021

Feb 14, 2022
SELL
$25.89 - $33.45 $302,265 - $390,528
-11,675 Reduced 3.99%
281,126 $7.66 Million
Q3 2021

Nov 09, 2021
SELL
$22.46 - $29.47 $174,536 - $229,011
-7,771 Reduced 2.59%
292,801 $8.06 Million
Q2 2021

Jul 29, 2021
SELL
$24.17 - $36.01 $1.06 Million - $1.58 Million
-43,746 Reduced 12.71%
300,572 $8.55 Million
Q1 2021

May 14, 2021
SELL
$32.28 - $44.3 $565,932 - $776,667
-17,532 Reduced 4.85%
344,318 $11.7 Million
Q4 2020

Feb 16, 2021
SELL
$31.45 - $40.54 $3.78 Million - $4.87 Million
-120,157 Reduced 24.93%
361,850 $12 Million
Q3 2020

Nov 16, 2020
BUY
$26.0 - $34.5 $1.43 Million - $1.9 Million
55,111 Added 12.91%
482,007 $15.5 Million
Q2 2020

Aug 14, 2020
SELL
$14.11 - $29.42 $141,226 - $294,464
-10,009 Reduced 2.29%
426,896 $11.8 Million
Q1 2020

May 15, 2020
SELL
$13.63 - $33.98 $181,319 - $452,035
-13,303 Reduced 2.95%
436,905 $7 Million
Q4 2019

Jan 29, 2020
SELL
$16.12 - $24.98 $198,582 - $307,728
-12,319 Reduced 2.66%
450,208 $10.8 Million
Q3 2019

Oct 30, 2019
SELL
$15.49 - $25.78 $77,666 - $129,260
-5,014 Reduced 1.07%
462,527 $8.16 Million
Q2 2019

Aug 01, 2019
SELL
$23.0 - $32.19 $450,133 - $629,990
-19,571 Reduced 4.02%
467,541 $12 Million
Q1 2019

May 01, 2019
BUY
$13.91 - $31.15 $1.06 Million - $2.37 Million
76,038 Added 18.5%
487,112 $14.2 Million
Q4 2018

Feb 14, 2019
BUY
$11.6 - $18.7 $1.56 Million - $2.52 Million
134,620 Added 48.7%
411,074 $5.39 Million
Q3 2018

Oct 25, 2018
SELL
$18.95 - $28.08 $127,533 - $188,978
-6,730 Reduced 2.38%
276,454 $5.59 Million
Q2 2018

Aug 02, 2018
BUY
$20.0 - $29.72 $429,440 - $638,147
21,472 Added 8.2%
283,184 $6.7 Million
Q1 2018

Apr 25, 2018
BUY
$21.69 - $32.99 $5.68 Million - $8.63 Million
261,712 New
261,712 $5.89 Million

Others Institutions Holding INSM

# of Institutions
489
Shares Held
197M
Call Options Held
892K
Put Options Held
1.77M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $13.2B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Rice Hall James & Associates, LLC Portfolio

Follow Rice Hall James & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email